Literature DB >> 15733558

Sensory nerve desensitization by resiniferatoxin improves glucose tolerance and increases insulin secretion in Zucker Diabetic Fatty rats and is associated with reduced plasma activity of dipeptidyl peptidase IV.

Dorte X Gram1, Anker J Hansen, Carolyn F Deacon, Christian L Brand, Ulla Ribel, Michael Wilken, Richard D Carr, Ove Svendsen, Bo Ahrén.   

Abstract

Sensory nerve desensitization by capsaicin has been shown to improve the diabetic condition in Zucker Diabetic Fatty rats. However, administration of capsaicin to adult rats is associated with an increased mortality. Therefore, in this experiment, we examined the influence of resiniferatoxin, a tolerable analogue of capsaicin suitable for in vivo use, on the diabetic condition of Zucker Diabetic Fatty rats. A single subcutaneous injection of resiniferatoxin (0.01 mg/kg) to these rats was tolerable, with no mortality. When administered to early diabetic rats at 15 weeks of age, the further deterioration of glucose homeostasis was prevented by resiniferatoxin. Further, when administered to overtly diabetic rats at 19 weeks of age, resiniferatoxin markedly improved glucose tolerance at two weeks after administration and this was accompanied by an increased insulin response to oral glucose as well as a reduction in the plasma levels of dipeptidyl peptidase IV. Therefore, resiniferatoxin is a safe alternative to capsaicin for further investigations of the role of the sensory nerves in experimental diabetes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15733558     DOI: 10.1016/j.ejphar.2004.12.039

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  17 in total

1.  Determination of body fat distribution by dual-energy X-ray absorptiometry and attenuation of visceral fat vasoconstriction by enalapril.

Authors:  Felix W Leung; Samuel Murray; Elsa Murray; Vay Liang Go
Journal:  Dig Dis Sci       Date:  2007-10-16       Impact factor: 3.199

Review 2.  Crosstalk between the nociceptive and immune systems in host defence and disease.

Authors:  Stephen B McMahon; Federica La Russa; David L H Bennett
Journal:  Nat Rev Neurosci       Date:  2015-07       Impact factor: 34.870

Review 3.  Targeting TRPV1 as an alternative approach to narcotic analgesics to treat chronic pain conditions.

Authors:  Louis S Premkumar
Journal:  AAPS J       Date:  2010-05-04       Impact factor: 4.009

Review 4.  Relations between metabolic homeostasis, diet, and peripheral afferent neuron biology.

Authors:  Tamara N Dunn; Sean H Adams
Journal:  Adv Nutr       Date:  2014-07-14       Impact factor: 8.701

5.  Relative contributions of afferent vagal fibers to resistance to diet-induced obesity.

Authors:  A T Stearns; A Balakrishnan; A Radmanesh; S W Ashley; D B Rhoads; A Tavakkolizadeh
Journal:  Dig Dis Sci       Date:  2011-12-03       Impact factor: 3.199

6.  Capsaicin inhibits Porphyromonas gingivalis growth, biofilm formation, gingivomucosal inflammatory cytokine secretion, and in vitro osteoclastogenesis.

Authors:  Y Zhou; X Guan; W Zhu; Z Liu; X Wang; H Yu; H Wang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-08-17       Impact factor: 3.267

Review 7.  TRP channels and their implications in metabolic diseases.

Authors:  Zhiming Zhu; Zhidan Luo; Shuangtao Ma; Daoyan Liu
Journal:  Pflugers Arch       Date:  2010-11-26       Impact factor: 3.657

Review 8.  TRP channels and analgesia.

Authors:  Louis S Premkumar; Mruvil Abooj
Journal:  Life Sci       Date:  2012-08-14       Impact factor: 5.037

9.  Deletion of the insulin receptor in sensory neurons increases pancreatic insulin levels.

Authors:  Caleb W Grote; Natalie M Wilson; Natalie K Katz; Brianne L Guilford; Janelle M Ryals; Lesya Novikova; Lisa Stehno-Bittel; Douglas E Wright
Journal:  Exp Neurol       Date:  2018-04-09       Impact factor: 5.330

10.  Selective targeting of TRPV1 expressing sensory nerve terminals in the spinal cord for long lasting analgesia.

Authors:  Joseph A Jeffry; Shuang-Quan Yu; Parul Sikand; Arti Parihar; M Steven Evans; Louis S Premkumar
Journal:  PLoS One       Date:  2009-09-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.